CoChat

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Comorbidity between ADHD and anxiety disorders across the lifespan

D’Agati, Elisa, Curatolo, Paolo, Mazzone, Luigi · 2019 · International Journal of Psychiatry in Clinical Practice

Abstract

Objectives: Attention deficit/hyperactivity disorder (ADHD) and anxiety disorders are among the most common psychiatric disorders with a 25% comorbidity rate with each other. In this study, we overview the comorbidity between ADHD and anxiety disorders in a longitudinal perspective across the lifespan and we discuss possible therapeutic strategies.Methods: A literature search was performed using PubMed to identify clinical studies assessing comorbidity between ADHD and anxiety disorders from childhood to adulthood.Results: Anxiety disorders may substantially change the presentation, the prognosis, and the treatment of ADHD itself. In childhood, the presence of generalised anxiety disorder, could prevent the typical inhibitory dysfunction present in ADHD, in adolescence may increase the deficit of working memory, and in adulthood may enhance the presence of sleep problems. Individuals with comorbid ADHD and anxiety disorders would benefit from adjunctive psychosocial or adjunctive pharmacotherapy interventions to cognitive behavioural treatment.Conclusions: The management of individuals with comorbid ADHD and anxiety disorders could be challenging for clinicians, and assessing the developmental course is crucial in order to shed light on individualised treatment.KeypointsThe comorbidity between ADHD and anxiety disorders changes the clinical presentation, the prognosis and treatment of patients with ADHD across lifespan.ADHD and anxiety disorders shared common neurobiological dysfunctions but have also different neurobiological abnormalities suggesting that they are different diagnoses.These patients are less likely to benefit from cognitive behavioural treatment strategies alone and often need adjunctive pharmacological treatments.Studies that evaluated the response to MPH reported conflicting results. These patients could respond less well and get more unpleasant arousal side-effects, but these findings need to be confirmed.For his unique mechanism of action, low dose aripiprazole treatment in adolescents and adults with this comorbid condition could be an intriguing avenue of exploration.

Overview

Integrity signals

Registry

Crossref · 10.1080/13651501.2019.1628277

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 69 references

Research works printed but not linked: 3

  1. 10.1207/153744202753441738 · DOI · Paper page
  2. 10.1177/0883073808331086 · DOI
  3. 10.1176/appi.ajp.163.4.716 · doi:10.1176/appi.ajp.163.4.716 · Paper page

Cited by

See all 165

Metadata

Authors
D’Agati, E., Curatolo, P., & Mazzone, L.
Affiliations
University of Rome Tor Vergata (IT)
Corresponding author
D’Agati, Elisa
Venue
International Journal of Psychiatry in Clinical Practice
Published
2019-06-24
Volume
23
Issue
4
Pages
238-244
ISSN
  • 1365-1501 (ISSN-L)
  • 1471-1788
OpenAlex
W2954062513
Cited by
165
References
69
Citations by year
2026: 25 · 2025: 31 · 2024: 39 · 2023: 25 · 2022: 19 · 2021: 18 · 2020: 8
FWCI
8.94
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Psychiatry in Clinical Practice (publishedVersion)
  • PubMed (publishedVersion)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
attention deficit hyperactivity disorder, anxiety disorders, comorbidities, lifespan development, generalized anxiety disorder, working memory deficits, sleep disorders, cognitive behavioral therapy, adjunctive pharmacotherapy, methylphenidate response, aripiprazole, inhibitory dysfunction, prognosis
MeSH terms
Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Humans, Comorbidity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comorbidity between ADHD and anxiety disorders across the lifespan. https://app.cochat.ai/papers/10.1080/13651501.2019.1628277
The paper
D’Agati, E., Curatolo, P., & Mazzone, L. (2019). Comorbidity between ADHD and anxiety disorders across the lifespan. International Journal of Psychiatry in Clinical Practice. https://doi.org/10.1080/13651501.2019.1628277

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.